Connected Inhalers and Digital Health in the USA: Regulatory Perspectives
Lee JJ.
Respiratory Drug Delivery 2020. Volume 1, 2020: 271-272.
Abstract:
The FDA’s Center for Devices and Radiological Health (CDRH) has established the Digital Health program, which seeks to better protect and promote public health and provide continued regulatory clarity by:
• Fostering collaborations and enhancing outreach to digital health customers, and
• Developing and implementing regulatory strategies and policies for digital health technologies.
This presentation will address current regulatory perspectives on connected inhalers and digital health in the USA.
I have a subscription
Log in for instant access.
I do not have a subscription
Purchase Article (in PDF format)
